SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001654954-21-001679
Filing Date
2021-02-16
Accepted
2021-02-16 08:24:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT camberglyc-202013ga.htm SC 13G/A 62501
2 JOINT FILING AGREEMENT glyc13ga2020ex1.htm EX-1 4969
  Complete submission text file 0001654954-21-001679.txt   69063
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87811 | Film No.: 21632764
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LP (Filed by) CIK: 0001444043 (see all company filings)

IRS No.: 421693587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A